We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
+14.24%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.19B
AUM Growth
-$189M
Cap. Flow
-$471M
Cap. Flow %
-21.5%
Top 10 Hldgs %
25.76%
Holding
204
New
59
Increased
25
Reduced
88
Closed
32

Top Buys

Rank Stock Value
1
SEDG icon
SolarEdge
SEDG
+$41.5M
2
ILMN icon
Illumina
ILMN
+$40.9M
3
QDEL icon
QuidelOrtho
QDEL
+$34.1M
4
CIVI
Civitas Resources
CIVI
+$18.5M
5
FMC icon
FMC
FMC
+$17.3M

Top Sells

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$245M
2
AAPL icon
Apple
AAPL
+$85.6M
3
BMY icon
Bristol-Myers Squibb
BMY
+$56.2M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$40.7M
5
CPAY icon
Corpay
CPAY
+$40.2M

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Consumer Discretionary 12.94%
3 Healthcare 12.41%
4 Communication Services 8.9%
5 Industrials 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOCO icon
151
El Pollo Loco
LOCO
$463M
$1.46M 0.07%
165,281
-96,835
-37% -$833K
LYEL icon
152
Lyell Immunopharma
LYEL
$351M
$1.45M 0.07%
+37,321
New +$1.34M
CEVA icon
153
CEVA Inc
CEVA
$889M
$1.37M 0.06%
60,499
-57,043
-49% -$1.17M
XERS icon
154
Xeris Biopharma Holdings
XERS
$1.46B
$1.34M 0.06%
+568,619
New +$1.05M
UPLD icon
155
Upland Software
UPLD
$14.5M
$1.26M 0.06%
29,710
-42,821
-59% -$1.85M
LASR icon
156
nLIGHT
LASR
$2.88B
$1.14M 0.05%
+84,377
New +$944K
ECHO
157
EchoStar
ECHO
$25.9B
$1.08M 0.05%
65,403
-47,847
-42% -$616K
CSTE icon
158
Caesarstone
CSTE
$88.2M
$1.01M 0.05%
269,334
-103,422
-28% -$417K
NAK
159
Northern Dynasty Minerals
NAK
$953M
$947K 0.04%
+2,928,855
New +$974K
LEXX icon
160
Lexaria Bioscience
LEXX
$9.07M
$915K 0.04%
48,799
-2,156
-4% -$41.6K
APP icon
161
Applovin
APP
$113B
$903K 0.04%
22,669
-560,744
-96% -$22M
PHX
162
DELISTED
PHX Minerals
PHX
$891K 0.04%
276,700
-12,259
-4% -$42.1K
SA
163
Seabridge Gold
SA
$3.36B
$878K 0.04%
72,420
-52,959
-42% -$609K
ASTL icon
164
Algoma Steel
ASTL
$468M
$873K 0.04%
87,002
-82,019
-49% -$635K
TBRG
165
DELISTED
TruBridge
TBRG
$846K 0.04%
75,526
-59,332
-44% -$752K
MAGN
166
Magnera Corp
MAGN
$466M
$773K 0.04%
30,635
-18,937
-38% -$399K
FORR icon
167
Forrester Research
FORR
$221M
$746K 0.03%
27,824
-20,443
-42% -$533K
TWKS
168
DELISTED
Thoughtworks Holding, Inc. Common Stock
TWKS
$628K 0.03%
130,557
-93,213
-42% -$383K
OGN icon
169
Organon & Co
OGN
$3.58B
$605K 0.03%
41,951
-204,866
-83% -$2.79M
CVEO icon
170
Civeo
CVEO
$330M
$476K 0.02%
20,816
-15,966
-43% -$345K
SNBR
171
DELISTED
Sleep Number
SNBR
$221K 0.01%
+14,932
New +$232K
AAPL icon
172
Apple
AAPL
$4.5T
– –
-500,000
Closed -$85.6M
AUDC icon
173
AudioCodes
AUDC
$255M
– –
-234,267
Closed -$2.37M
BHR
174
Braemar Hotels & Resorts
BHR
$139M
– –
-105,327
Closed -$292K
BMY icon
175
Bristol-Myers Squibb
BMY
$132B
– –
-968,234
Closed -$56.2M
5 6
7
8 9

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2023 Portfolio in Review

As of Q4 2023, Invenomic Capital Management held 204 positions worth $2.19B, down 7.9% from $2.38B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Invenomic Capital Management withdrew a net $471M in Q4 2023, closing 32 positions and reducing 88 holdings. Its most notable exit was State Street SPDR S&P 500 ETF Trust, an estimated $245M position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Invenomic Capital Management opened a new position in SolarEdge worth $42.6M.

  • Invenomic Capital Management's largest Q4 2023 buy was SolarEdge: 455,600 shares worth $42.6M.
  • Invenomic Capital Management added most to IPG Photonics in Q4 2023, an estimated $11.6M increase.
  • Invenomic Capital Management's biggest Q4 2023 reduction was Corpay, cutting an estimated $40.2M.
  • Invenomic Capital Management fully exited State Street SPDR S&P 500 ETF Trust in Q4 2023, selling an estimated $245M.
  • Invenomic Capital Management's ten largest holdings make up 26% of its $2.19B portfolio in Q4 2023.
  • Invenomic Capital Management opened 59 new positions and closed 32 in Q4 2023.
  • Invenomic Capital Management's portfolio value fell 7.9% quarter-over-quarter to $2.19B.

Based on Invenomic Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.